[Apex Biotech] May 2026 Revenue Reaches NT$ 146 Million (Down 18.1% YoY)
Apex Biotechnology Corp. announced its May 2026 monthly revenue of NT$ 145.66 million, representing an 18.1% decline compared to the same period last year.
📋 Article Processing Timeline
- 📰 Published: May 1, 2026 at 09:00
- 🔍 Collected: June 12, 2026 at 08:00 (1007h 0m after Published)
- 🤖 AI Analyzed: June 12, 2026 at 16:45 (8h 44m after Collected)
Company Code: 1733
Company Name: Apex Biotechnology
Industry Sector: Biotechnology and Medical Care
Reporting Month: May 2026
Monthly Revenue: NT$ 145,664 thousand (approx. NT$ 146 million)
Year-on-Year Growth/Decline: -18.1%
Company Name: Apex Biotechnology
Industry Sector: Biotechnology and Medical Care
Reporting Month: May 2026
Monthly Revenue: NT$ 145,664 thousand (approx. NT$ 146 million)
Year-on-Year Growth/Decline: -18.1%
FAQ
What is Apex Biotechnology's revenue for May 2026?
The monthly revenue is NT$ 145,664 thousand (approximately NT$ 146 million).
How did the revenue change compared to the previous year?
It decreased by 18.1% compared to May 2025.
What is the industry sector of Apex Biotechnology?
It is categorized under the Biotechnology and Medical Care industry.